Winner Profile
Anping Li
CEO, Shanxi Zhendong Pharmaceutical
Industry: Pharmaceuticals
Company size: Large
Published: 2016-10-17
Is Shanxi Zhendong Pharmaceutical a good stock investment?
Based on the annual Obermatt CEO of the Year analysis, Anping Li (Shanxi Zhendong Pharmaceutical) earned the following Obermatt pins for the management performance.
Obermatt accolades Anping Li
| Year | Pin | Category |
|---|---|---|
| 2016 |  |
Investment Performance |
|
Growth Performance | |
|
Combined Performance | |
|
Operating Performance | |
| 2015 |  |
Growth Performance |
| 2014 |  |
Investment Performance |
|
Growth Performance | |
|
Combined Performance |
Anping Li was included in the competition among China Top 100 Growth Companies (China) (current winners). See the winners of the other competitions or how the CEOs performed over all competitions.
Performance Overview Anping Li
In summary, Anping Li obtained the following achievements in the individual Obermatt categories by participating in the Obermatt rankings (averages of all evaluated rankings are shown for this CEO, also for other companies):
CEO performance is displayed relative to that of other CEOs that competed in the same categories for the same number of competitions. A ranking of 64 in Combined Performance indicates that Anping Li was better than 64% of all other CEOs that were analyzed as part of the China Top 100 Growth Companies – China for three participations in Obermatt CEO competitions. Anping Li’s average ranking can be found in the Multi-Year Rankings for China Top 100 Growth Companies - China.